Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Medtronic is a global leader in medical technology, developing and manufacturing innovative medical devices and offering advanced therapies to improve healthcare and patient quality of life. Key business areas include Cardiovascular, Diabetes, Neuroscience, and Minimally Invasive Surgery.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Medtronic (MDT) is scheduled to release its Q2 2026 financial results on September 1, 2026, before the market open. Analysts estimate an earnings per share (EPS) of 1.39 USD on revenue of 9,549 million USD. In the last reported quarter, Q1 2026, the company reported an EPS of 1.55 USD, which beat the estimate of 1.54 USD by 0.6%.
Generated automatically from our data — as of 08/20/2026
Medtronic is scheduled to report its next quarterly earnings on 09/01/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Medtronic last reported quarterly earnings on 6/3/2026 (Q1 2026). Earnings per share (EPS) came in at 1.55 USD.
Across its last 3 earnings reports, Medtronic stock moved by ±4.5% on average the following day. The largest reaction was +5.7% on 06/03/2026; 2 of 3 reactions were positive.
Medtronic has beaten analyst EPS estimates in 4 of its last 4 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.